"Ampicillin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Descriptor ID |
D000667
|
MeSH Number(s) |
D02.065.589.099.750.750.050 D02.886.108.750.750.050 D03.633.100.300.750.750.050
|
Concept/Terms |
Ampicillin- Ampicillin
- Aminobenzylpenicillin
- Penicillin, Aminobenzyl
- Aminobenzyl Penicillin
|
Below are MeSH descriptors whose meaning is more general than "Ampicillin".
Below are MeSH descriptors whose meaning is more specific than "Ampicillin".
This graph shows the total number of publications written about "Ampicillin" by people in this website by year, and whether "Ampicillin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ampicillin" by people in Profiles.
-
Enteroviral Meningoencephalitis Complicated by Central Diabetes Insipidus in a Neonate: A Case Report and Review of the Literature. J Pediatric Infect Dis Soc. 2015 Jun; 4(2):155-8.
-
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci. Chemotherapy. 1996 Jul-Aug; 42(4):235-9.
-
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species. Diagn Microbiol Infect Dis. 1995 Aug; 22(4):349-52.
-
Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrob Agents Chemother. 1994 Jun; 38(6):1225-9.
-
In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis. Diagn Microbiol Infect Dis. 1992 May-Jun; 15(4):371-3.